Literature DB >> 11565864

Analysis of hearing loss after shunt placement in patients with normal-pressure hydrocephalus.

M L van Veelen-Vincent1, E J Delwel, R Teeuw, E Kurt, D A de Jong, M P Brocaar, B K Pauw, C J Avezaat, B G van Zanten.   

Abstract

OBJECT: Following shunt placement for treatment of normal-pressure hydrocephalus (NPH), several patients suffered hearing loss. The authors undertook a study to analyze this outcome.
METHODS: Sixteen patients in whom NPH was diagnosed were treated by placement of a ventriculoperitoneal shunt. Their hearing was assessed pre- and postoperatively by using pure tone audiometry. Two thirds of the ears tested showed a postoperative hearing loss of more than 10 dB. Recovery of the hearing loss occurred 6 to 12 weeks after shunt placement in 75% of the ears examined.
CONCLUSIONS: Although shunt insertion for treatment of NPH results in a decrease in hearing, most of the loss can be recovered.

Entities:  

Mesh:

Year:  2001        PMID: 11565864     DOI: 10.3171/jns.2001.95.3.0432

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

Review 1.  Hearing loss in hydrocephalus: a review, with focus on mechanisms.

Authors:  David Satzer; Daniel J Guillaume
Journal:  Neurosurg Rev       Date:  2015-08-18       Impact factor: 3.042

2.  Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.

Authors:  Johnnie K Bass; Chia-Ho Hua; Jie Huang; Arzu Onar-Thomas; Kirsten K Ness; Skye Jones; Stephanie White; Shaum P Bhagat; Kay W Chang; Thomas E Merchant
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

3.  To Evaluate the Pre and Post Shunt Sensorineural Hearing Loss in Hydrocephalus Patients.

Authors:  Manish Verma; Jagat Singh; Ishwar Singh; Vikas Kakkar; S P S Yadav; Jitu Sam George
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-08

Review 4.  Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.

Authors:  Eva Clemens; Marry M van den Heuvel-Eibrink; Renée L Mulder; Leontien C M Kremer; Melissa M Hudson; Roderick Skinner; Louis S Constine; Johnnie K Bass; Claudia E Kuehni; Thorsten Langer; Elvira C van Dalen; Edith Bardi; Nicolas-Xavier Bonne; Penelope R Brock; Beth Brooks; Bruce Carleton; Eric Caron; Kay W Chang; Karen Johnston; Kristin Knight; Paul C Nathan; Etan Orgel; Pinki K Prasad; Jan Rottenberg; Katrin Scheinemann; Andrica C H de Vries; Thomas Walwyn; Annette Weiss; Antoinette Am Zehnhoff-Dinnesen; Richard J Cohn; Wendy Landier
Journal:  Lancet Oncol       Date:  2019-01       Impact factor: 54.433

5.  PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus.

Authors:  Yuki Nagata; Masahiko Bundo; Saiko Sugiura; Masahiro Kamita; Masaya Ono; Kotaro Hattori; Sumiko Yoshida; Yu-Ichi Goto; Katsuya Urakami; Shumpei Niida
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

6.  Aqueductal CSF stroke volume measurements may drive management of shunted idiopathic normal pressure hydrocephalus patients.

Authors:  Antonio Scollato; Saverio Caini; Lucia Angelini; Giancarlo Lastrucci; Nicola Di Lorenzo; Berardino Porfirio; Pasquale Gallina
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

7.  Profound hearing loss following surgery in pediatric patients with posterior fossa low-grade glioma.

Authors:  Yahya Ghazwani; Ibrahim Qaddoumi; Johnnie K Bass; Shengjie Wu; Jason Chiang; Frederick Boop; Amar Gajjar; Zsila Sadighi
Journal:  Neurooncol Pract       Date:  2017-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.